SYS-CON MEDIA Authors: Lori MacVittie, RealWire News Distribution, Kevin Remde

News Feed Item

Novo Nordisk A/S: Tresiba(R) (insulin degludec) approved in Japan

BAGSVAERD, DENMARK -- (Marketwire) -- 09/28/12 --


Company Announcement No 59 2012: http://hugin.info/2013/R/1644197/529643.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1644197]

Media:
Mike Rulis
Tel: (+45) 3079 3573
Email Contact

In North America:
Ken Inchausti
Tel: (+1) 609 514 8316
Email Contact

Investors:
Kasper Roseeuw Poulsen
Tel: (+45) 4442 4303
Email Contact

Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact

Lars Borup Jacobsen
Tel: (+45) 3075 3479
Email Contact

Jannick Lindegaard
Tel: (+1) 609 786 4575
Email Contact

More Stories By Marketwire .

Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.